Cardiac function in types II and III spinal muscular atrophy: Should we change standards of care?

Flaviana Bianco, Marika Pane, Adele D'Amico, Sonia Messina, Angelica Bibiana Delogu, Gianni Soraru, Maria Carmela Pera, Tiziana Mongini, Luisa Politano, Giovanni Baranello, Gianluca Vita, Francesco Danilo Tiziano, Lucia Morandi, Enrico Bertini, Eugenio Mercuri

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA. Patients and Methods We retrospectively reviewed 24-hour electrocardiography (ECG) in 157 types II and III SMA patients (age range, 2-74 years). Of them, 82 also had echocardiography. Results None of the patients had signs of bradycardia, atrial fibrillation, or the other previously reported rhythm disturbances regardless of the age at examination or the type of SMA. Echocardiography was also normal. There were no signs of congenital cardiac defects with the exception of one patient with a history of ventricular septal defects. Conclusions Our results suggest that cardiac abnormalities are not common in type II and type III SMA. These findings provide no evidence to support a more accurate cardiac surveillance or changes in the existing standards of care.

Original languageEnglish
Pages (from-to)33-36
Number of pages4
JournalNeuropediatrics
Volume46
Issue number1
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Spinal Muscular Atrophies of Childhood
Standard of Care
Spinal Muscular Atrophy
Echocardiography
Ventricular Heart Septal Defects
Bradycardia
Atrial Fibrillation
Electrocardiography
Animal Models
Heart Rate

Keywords

  • cardiac function
  • SMA
  • standard of care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology
  • Medicine(all)

Cite this

Cardiac function in types II and III spinal muscular atrophy : Should we change standards of care? / Bianco, Flaviana; Pane, Marika; D'Amico, Adele; Messina, Sonia; Delogu, Angelica Bibiana; Soraru, Gianni; Pera, Maria Carmela; Mongini, Tiziana; Politano, Luisa; Baranello, Giovanni; Vita, Gianluca; Tiziano, Francesco Danilo; Morandi, Lucia; Bertini, Enrico; Mercuri, Eugenio.

In: Neuropediatrics, Vol. 46, No. 1, 01.02.2015, p. 33-36.

Research output: Contribution to journalArticle

Bianco, F, Pane, M, D'Amico, A, Messina, S, Delogu, AB, Soraru, G, Pera, MC, Mongini, T, Politano, L, Baranello, G, Vita, G, Tiziano, FD, Morandi, L, Bertini, E & Mercuri, E 2015, 'Cardiac function in types II and III spinal muscular atrophy: Should we change standards of care?', Neuropediatrics, vol. 46, no. 1, pp. 33-36. https://doi.org/10.1055/s-0034-1395348
Bianco, Flaviana ; Pane, Marika ; D'Amico, Adele ; Messina, Sonia ; Delogu, Angelica Bibiana ; Soraru, Gianni ; Pera, Maria Carmela ; Mongini, Tiziana ; Politano, Luisa ; Baranello, Giovanni ; Vita, Gianluca ; Tiziano, Francesco Danilo ; Morandi, Lucia ; Bertini, Enrico ; Mercuri, Eugenio. / Cardiac function in types II and III spinal muscular atrophy : Should we change standards of care?. In: Neuropediatrics. 2015 ; Vol. 46, No. 1. pp. 33-36.
@article{5879318b4b3e4c64b6037cbd753b9a1e,
title = "Cardiac function in types II and III spinal muscular atrophy: Should we change standards of care?",
abstract = "Objective In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA. Patients and Methods We retrospectively reviewed 24-hour electrocardiography (ECG) in 157 types II and III SMA patients (age range, 2-74 years). Of them, 82 also had echocardiography. Results None of the patients had signs of bradycardia, atrial fibrillation, or the other previously reported rhythm disturbances regardless of the age at examination or the type of SMA. Echocardiography was also normal. There were no signs of congenital cardiac defects with the exception of one patient with a history of ventricular septal defects. Conclusions Our results suggest that cardiac abnormalities are not common in type II and type III SMA. These findings provide no evidence to support a more accurate cardiac surveillance or changes in the existing standards of care.",
keywords = "cardiac function, SMA, standard of care",
author = "Flaviana Bianco and Marika Pane and Adele D'Amico and Sonia Messina and Delogu, {Angelica Bibiana} and Gianni Soraru and Pera, {Maria Carmela} and Tiziana Mongini and Luisa Politano and Giovanni Baranello and Gianluca Vita and Tiziano, {Francesco Danilo} and Lucia Morandi and Enrico Bertini and Eugenio Mercuri",
year = "2015",
month = "2",
day = "1",
doi = "10.1055/s-0034-1395348",
language = "English",
volume = "46",
pages = "33--36",
journal = "Neuropediatrics",
issn = "0174-304X",
publisher = "Hippokrates Verlag GmbH",
number = "1",

}

TY - JOUR

T1 - Cardiac function in types II and III spinal muscular atrophy

T2 - Should we change standards of care?

AU - Bianco, Flaviana

AU - Pane, Marika

AU - D'Amico, Adele

AU - Messina, Sonia

AU - Delogu, Angelica Bibiana

AU - Soraru, Gianni

AU - Pera, Maria Carmela

AU - Mongini, Tiziana

AU - Politano, Luisa

AU - Baranello, Giovanni

AU - Vita, Gianluca

AU - Tiziano, Francesco Danilo

AU - Morandi, Lucia

AU - Bertini, Enrico

AU - Mercuri, Eugenio

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objective In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA. Patients and Methods We retrospectively reviewed 24-hour electrocardiography (ECG) in 157 types II and III SMA patients (age range, 2-74 years). Of them, 82 also had echocardiography. Results None of the patients had signs of bradycardia, atrial fibrillation, or the other previously reported rhythm disturbances regardless of the age at examination or the type of SMA. Echocardiography was also normal. There were no signs of congenital cardiac defects with the exception of one patient with a history of ventricular septal defects. Conclusions Our results suggest that cardiac abnormalities are not common in type II and type III SMA. These findings provide no evidence to support a more accurate cardiac surveillance or changes in the existing standards of care.

AB - Objective In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA. Patients and Methods We retrospectively reviewed 24-hour electrocardiography (ECG) in 157 types II and III SMA patients (age range, 2-74 years). Of them, 82 also had echocardiography. Results None of the patients had signs of bradycardia, atrial fibrillation, or the other previously reported rhythm disturbances regardless of the age at examination or the type of SMA. Echocardiography was also normal. There were no signs of congenital cardiac defects with the exception of one patient with a history of ventricular septal defects. Conclusions Our results suggest that cardiac abnormalities are not common in type II and type III SMA. These findings provide no evidence to support a more accurate cardiac surveillance or changes in the existing standards of care.

KW - cardiac function

KW - SMA

KW - standard of care

UR - http://www.scopus.com/inward/record.url?scp=84929331745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929331745&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1395348

DO - 10.1055/s-0034-1395348

M3 - Article

C2 - 25539139

AN - SCOPUS:84929331745

VL - 46

SP - 33

EP - 36

JO - Neuropediatrics

JF - Neuropediatrics

SN - 0174-304X

IS - 1

ER -